North America Drugs for Schistosomiasis Market by Manufacturers, Countries, Type and Application, Forecast to 2022

1 Market Overview

1.1 Drugs for Schistosomiasis Introduction

1.2 Market Analysis by Type

1.2.1 Praziquantel

1.2.2 Oxamniquine

1.2.3 Other

1.3 Market Analysis by Applications

1.3.1 S. haematobium

1.3.2 S. mansoni

1.3.3 S. japonicum

1.3.4 S. mekongi

1.3.5 S. intercalatum

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 Mexico Status and Prospect (2012-2022)

1.4.3 Canada Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Shin Poong

2.1.1 Profile

2.1.2 Drugs for Schistosomiasis Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Shin Poong News

2.2 Merck

2.2.1 Profile

2.2.2 Drugs for Schistosomiasis Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Merck News

2.3 Bayer

2.3.1 Profile

2.3.2 Drugs for Schistosomiasis Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 Bayer News

2.4 EIPICO

2.4.1 Profile

2.4.2 Drugs for Schistosomiasis Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 EIPICO News

2.5 Chandra Bhagat Pharma

2.5.1 Profile

2.5.2 Drugs for Schistosomiasis Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Chandra Bhagat Pharma News

2.6 Taj Pharmaceuticals

2.6.1 Profile

2.6.2 Drugs for Schistosomiasis Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Taj Pharmaceuticals News

3 North America Drugs for Schistosomiasis Market Competition, by Manufacturer

3.1 North America Drugs for Schistosomiasis Sales and Market Share by Manufacturer (2016-2017)

3.2 North America Drugs for Schistosomiasis Revenue and Market Share by Manufacturer (2016-2017)

3.3 North America Drugs for Schistosomiasis Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share

3.4.2 Top 5 Drugs for Schistosomiasis Manufacturer Market Share

3.5 Market Competition Trend

4 North America Drugs for Schistosomiasis Market Analysis by Countries

4.1 North America Drugs for Schistosomiasis Sales Market Share by Countries

4.2 North America Drugs for Schistosomiasis Sales by Countries (2012-2017)

4.3 North America Drugs for Schistosomiasis Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Drugs for Schistosomiasis by Type

5.1 North America Drugs for Schistosomiasis Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 North America Drugs for Schistosomiasis Sales and Market Share by Type (2012-2017)

5.1.2 North America Drugs for Schistosomiasis Revenue and Market Share by Type (2012-2017)

5.2 Praziquantel Sales Growth and Price

5.2.1 North America Praziquantel Sales Growth (2012-2017)

5.2.2 North America Praziquantel Price (2012-2017)

5.3 Oxamniquine Sales Growth and Price

5.3.1 North America Oxamniquine Sales Growth (2012-2017)

5.3.2 North America Oxamniquine Price (2012-2017)

5.4 Other Sales Growth and Price

5.4.1 North America Other Sales Growth (2012-2017)

5.4.2 North America Other Price (2012-2017)

6 North America Market Segmentation Drugs for Schistosomiasis by Application

6.1 North America Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)

6.2 S. haematobium Sales Growth (2012-2017)

6.3 S. mansoni Sales Growth (2012-2017)

6.4 S. japonicum Sales Growth (2012-2017)

6.5 S. mekongi Sales Growth (2012-2017)

6.6 S. intercalatum Sales Growth (2012-2017)

7 United States Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)

7.2 United States Drugs for Schistosomiasis Sales and Market Share by Type

7.3 United States Drugs for Schistosomiasis Sales by Application (2012-2017)

7.4 United States Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer

7.4.1 United States Drugs for Schistosomiasis Sales and Market Share by Manufacturer

7.4.2 United States Drugs for Schistosomiasis Revenue and Market Share by Manufacturer

7.5 United States Drugs for Schistosomiasis Export and Import (2012-2017)

8 Canada Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers

8.1 Canada Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)

8.2 Canada Drugs for Schistosomiasis Sales and Market Share by Type

8.3 Canada Drugs for Schistosomiasis Sales by Application (2012-2017)

8.4 Canada Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer

8.4.1 Canada Drugs for Schistosomiasis Sales and Market Share by Manufacturer

8.4.2 Canada Drugs for Schistosomiasis Revenue and Market Share by Manufacturer

8.5 Canada Drugs for Schistosomiasis Export and Import (2012-2017)

9 Mexico Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers

9.1 Mexico Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)

9.2 Mexico Drugs for Schistosomiasis Sales and Market Share by Type

9.3 Mexico Drugs for Schistosomiasis Sales by Application (2012-2017)

9.4 Mexico Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer

9.4.1 Mexico Drugs for Schistosomiasis Sales and Market Share by Manufacturer

9.4.2 Mexico Drugs for Schistosomiasis Revenue and Market Share by Manufacturer

9.5 Mexico Drugs for Schistosomiasis Export and Import (2012-2017)

10 Drugs for Schistosomiasis Market Forecast (2017-2022)

10.1 North America Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)

10.2 Drugs for Schistosomiasis Market Forecast by Countries (2017-2022)

10.2.1 United States Drugs for Schistosomiasis Forecast (2017-2022)

10.2.2 Canada Drugs for Schistosomiasis Forecast (2017-2022)

10.2.3 Mexico Drugs for Schistosomiasis Forecast (2017-2022)

10.3 Drugs for Schistosomiasis Market Forecast by Type (2017-2022)

10.4 Drugs for Schistosomiasis Market Forecast by Application (2017-2022)

11 Drugs for Schistosomiasis Manufacturing Cost Analysis

11.1 Drugs for Schistosomiasis Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Drugs for Schistosomiasis

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Drugs for Schistosomiasis Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016

12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data SourceList of Tables and Figures

Figure Drugs for Schistosomiasis Picture

Table Product Specifications of Drugs for Schistosomiasis

Figure North America Sales Market Share of Drugs for Schistosomiasis by Types in 2016

Table Types of Drugs for Schistosomiasis

Figure Praziquantel Picture

Table Major Manufacturers of Praziquantel

Figure Oxamniquine Picture

Table Major Manufacturers of Oxamniquine

Figure Other Picture

Table Major Manufacturers of Other

Table North America Drugs for Schistosomiasis Sales Market Share by Applications in 2016

Table Applications of Drugs for Schistosomiasis

Figure S. haematobium Picture

Figure S. mansoni Picture

Figure S. japonicum Picture

Figure S. mekongi Picture

Figure S. intercalatum Picture

Figure United States Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)

Figure Mexico Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)

Figure Canada Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)

Table Shin Poong Basic Information, Manufacturing Base and Competitors

Table Shin Poong Drugs for Schistosomiasis Type and Applications

Table Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Drugs for Schistosomiasis Type and Applications

Table Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Drugs for Schistosomiasis Type and Applications

Table Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table EIPICO Basic Information, Manufacturing Base and Competitors

Table EIPICO Drugs for Schistosomiasis Type and Applications

Table EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors

Table Chandra Bhagat Pharma Drugs for Schistosomiasis Type and Applications

Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Taj Pharmaceuticals Drugs for Schistosomiasis Type and Applications

Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)

Figure North America Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016

Figure North America Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017

Table North America Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)

Figure North America Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016

Figure North America Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017

Table North America Drugs for Schistosomiasis Price by Manufacturers (2016-2017)

Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2016

Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2017

Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2016

Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2017

Figure North America Drugs for Schistosomiasis Sales and Growth (2012-2017)

Table North America Drugs for Schistosomiasis Sales by Countries (2012-2017)

Table North America Drugs for Schistosomiasis Sales Market Share by Countries (2012-2017)

Figure North America 2012 Drugs for Schistosomiasis Sales Market Share by Countries

Figure North America 2016 Drugs for Schistosomiasis Sales Market Share by Countries

Figure North America Drugs for Schistosomiasis Revenue and Growth (2012-2017)

Table North America Drugs for Schistosomiasis Revenue by Countries (2012-2017)

Table North America Drugs for Schistosomiasis Revenue Market Share by Countries (2012-2017)

Table North America 2012 Drugs for Schistosomiasis Revenue Market Share by Countries

Table North America 2016 Drugs for Schistosomiasis Revenue Market Share by Countries

Table North America Drugs for Schistosomiasis Sales by Type (2012-2017)

Table North America Drugs for Schistosomiasis Sales Share by Type (2012-2017)

Table North America Drugs for Schistosomiasis Revenue by Type (2012-2017)

Table North America Drugs for Schistosomiasis Revenue Share by Type (2012-2017)

Figure North America Praziquantel Sales Growth (2012-2017)

Figure North America Praziquantel Price (2012-2017)

Figure North America Oxamniquine Sales Growth (2012-2017)

Figure North America Oxamniquine Price (2012-2017)

Figure North America Other Sales Growth (2012-2017)

Figure North America Other Price (2012-2017)

Table North America Drugs for Schistosomiasis Sales by Application (2012-2017)

Table North America Drugs for Schistosomiasis Sales Share by Application (2012-2017)

Figure North America S. haematobium Sales Growth (2012-2017)

Figure North America S. mansoni Sales Growth (2012-2017)

Figure North America S. japonicum Sales Growth (2012-2017)

Figure North America S. mekongi Sales Growth (2012-2017)

Figure North America S. intercalatum Sales Growth (2012-2017)

Figure United States Drugs for Schistosomiasis Revenue and Growth (2012-2017)

Figure United States Drugs for Schistosomiasis Sales and Growth (2012-2017)

Table United States Drugs for Schistosomiasis Sales by Type (2012-2017)

Table United States Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)

Table United States Drugs for Schistosomiasis Sales by Application (2012-2017)

Table United States Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)

Table United States Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)

Figure United States Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016

Figure United States Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017

Table United States Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)

Figure United States Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016

Figure United States Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017

Table United States Drugs for Schistosomiasis Export and Import (2012-2017)

Figure Canada Drugs for Schistosomiasis Revenue and Growth (2012-2017)

Figure Canada Drugs for Schistosomiasis Sales and Growth (2012-2017)

Table Canada Drugs for Schistosomiasis Sales by Type (2012-2017)

Table Canada Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)

Table Canada Drugs for Schistosomiasis Sales by Application (2012-2017)

Table Canada Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)

Table Canada Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)

Figure Canada Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016

Figure Canada Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017

Table Canada Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)

Figure Canada Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016

Figure Canada Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017

Table Canada Drugs for Schistosomiasis Export and Import (2012-2017)

Figure Mexico Drugs for Schistosomiasis Revenue and Growth (2012-2017)

Figure Mexico Drugs for Schistosomiasis Sales and Growth (2012-2017)

Table Mexico Drugs for Schistosomiasis Sales by Type (2012-2017)

Table Mexico Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)

Table Mexico Drugs for Schistosomiasis Sales by Application (2012-2017)

Table Mexico Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)

Table Mexico Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)

Figure Mexico Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016

Figure Mexico Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017

Table Mexico Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)

Figure Mexico Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016

Figure Mexico Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017

Table Mexico Drugs for Schistosomiasis Export and Import (2012-2017)

Figure North America Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)

Table North America Drugs for Schistosomiasis Sales Forecast by Countries (2017-2022)

Table North America Drugs for Schistosomiasis Market Share Forecast by Countries (2017-2022)

Figure United States Drugs for Schistosomiasis Sales Forecast (2017-2022)

Figure Canada Drugs for Schistosomiasis Sales Forecast (2017-2022)

Figure Mexico Drugs for Schistosomiasis Sales Forecast (2017-2022)

Table North America Drugs for Schistosomiasis Sales Forecast by Type (2017-2022)

Table North America Drugs for Schistosomiasis Market Share Forecast by Type (2017-2022)

Table North America Drugs for Schistosomiasis Sales Forecast by Application (2017-2022)

Table North America Drugs for Schistosomiasis Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Drugs for Schistosomiasis

Figure Manufacturing Process Analysis of Drugs for Schistosomiasis

Figure Drugs for Schistosomiasis Industrial Chain Analysis

Table Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016

Table Major Buyers of Drugs for Schistosomiasis

Table Distributors/Traders/ Dealers List